Dr. Clayton Hudnall, MD
What this data tells you about Dr. Hudnall
Dr. Clayton Hudnall is an urology physician in San Antonio, TX, with 20 years in practice. Based on federal Medicare data, Dr. Hudnall performed 6,443 Medicare services across 3,789 unique beneficiaries.
Between the years covered by Open Payments, Dr. Hudnall received a total of $20,321 from 27 pharmaceutical and/or device companies across 104 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Hudnall is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Urinalysis with microscopic exam | 1,130 | $3 | $15 |
| Office visit, established patient (30-39 min) | 867 | $86 | $215 |
| Chronic care management, first 20 min/month | 679 | $40 | $79 |
| PSA test (prostate cancer screening) | 518 | $18 | $110 |
| Office visit, established patient (20-29 min) | 488 | $60 | $150 |
| Infectious disease DNA/RNA test | 485 | $33 | $78 |
| Blood draw (venipuncture) | 476 | $8 | $10 |
| Bladder ultrasound after voiding | 416 | $7 | $95 |
| Testosterone (hormone) level, total | 146 | $25 | $150 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 135 | $134 | $700 |
| New patient office visit (30-44 min) | 90 | $75 | $210 |
| Simple insertion of temporary bladder tube | 89 | $45 | $180 |
| New patient office visit (45-59 min) | 81 | $108 | $313 |
| Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | 81 | $130 | $811 |
| Biopsy of prostate gland | 80 | $92 | $350 |
| Ultrasound scan of pelvic region through rectum | 80 | $24 | $285 |
| Insertion of lower leg neurostimulator electrode | 76 | $87 | $275 |
| Diagnostic exam of bladder and urethra using an endoscope | 75 | $173 | $490 |
| Complete ultrasound scan behind abdominal cavity | 71 | $78 | $345 |
| Drug injection, under skin or into muscle | 52 | $10 | $30 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 46 | $24 | $75 |
| Simple change of bladder tube | 44 | $69 | $155 |
| Yeast/candida DNA test | 40 | $33 | $78 |
| Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique | 40 | $33 | $78 |
| Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique | 40 | $33 | $78 |
| Simple bladder irrigation and/or instillation | 36 | $48 | $215 |
| Basic metabolic blood panel | 24 | $8 | $45 |
| Red blood cell concentration measurement | 21 | $2 | $8 |
| Blood count, hemoglobin | 21 | $2 | $8 |
| Initial hospital admission, moderate complexity | 16 | $100 | $275 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (46%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in urology physician and does not inherently indicate bias, but patients may wish to be aware.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | — Not enrolled | N/A |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Hudnall is a clinical cardiology specialist, with above-average Medicare volume (top 16% in TX), and high industry engagement (speaking/promotional, top 12%), with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Hudnall experienced with urinalysis with microscopic exam?
Does Dr. Hudnall receive payments from pharmaceutical companies?
How do Dr. Hudnall's costs compare to other urology physicians in San Antonio?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology